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Plasma Lactate in septic peritonitis: a retrospective study of 83 dogs (2007-1 
2012) 2 
 3 
Abstract  4 
Objective: To determine if absolute lactate or lactate clearance in dogs with septic 5 
peritonitis is associated with morbidity and mortality.  6 
 7 
Design: Retrospective cohort study from 2007-2012. 8 
 9 
Setting: University teaching hospital accepting referrals and primary emergencies. 10 
Animals: Eighty-three dogs diagnosed with septic peritonitis were included. All the 11 
patients had at least one lactate measurement taken during the course of the 12 
hospitalization.  13 
 14 
Results: Sixty-four percent of the patients survived to discharge, 22% were euthanized 15 
and 14% died during hospitalization. Lactate concentration > 2.5 mmol/l on admission 16 
(29% of the patients) was associated with mortality (p=0.001). Median admission lactate 17 
(n=81) was significantly different between non-survivors (2.5 mmol/l, range 0.5-8.4) and 18 
survivors (1.4 mmol/l, range 0.5-9.7) (p=0.007). Admission lactate higher than 4 mmol/l 19 
yielded a sensitivity of 36% and a specificity of 92% for non-survival. The inability to 20 
normalise lactate within 6 hours (n=10/24) yielded a sensitivity of 76% and specificity 21 
of 100% for non-survival. Post-operative hyperlactatemia (n=18/76) had a sensitivity of 22 
46% and specificity of 88% for non-survival. Persistent post-operative hyperlactatemia 23 
(n=11/18) had a sensitivity of 92% and a specificity of 100% for non-survival. Regarding 24 
the lactate clearance at 6 hours, the area under the curve (AUC) (n=20) was 0.81 and the 25 
best cut-off was 21% (sensitivity 54% and specificity 91% for non-survival). AUC for 26 
lactate clearance at 12 hours (n=18) was 0.92, with the best cut-off value defined as 42% 27 
(sensitivity of 82% and a specificity of 100% for non-survival).  28 
 29 
Conclusions: In this study absolute lactate and lactate clearance were good prognostic 30 
indicators in septic peritonitis. Further studies are needed to assess its role as a 31 




Septic peritonitis is defined as the presence of microbial contamination of the 36 
peritoneal cavity1. It carries a high mortality with a reported survival to discharge rate in 37 
dogs ranging from 29% to 71% 1-3. 38 
Septic peritonitis can be either primary or secondary to intra-abdominal organ 39 
leakage2,3 and can lead, even with early surgical treatment, to septic shock. The 40 
pathophysiology of the disease is intimately related to the complexity of sepsis4, including 41 
systemic inflammation and its repercussions on major organ systems, cardiovascular 42 
instability and the underlying disease process responsible for the peritonitis. It is 43 
therefore difficult to identify a specific and reliable prognostic factor. In human medicine5 44 
there has been growing interest towards identification of biomarkers able to act not only 45 
as prognostic indicators but also as clinical indicators to guide therapy.  This interest has 46 
extended also to veterinary medicine6. 47 
Many studies, both in human and veterinary medicine, have examined absolute lactate 48 
level in the clinical context both for its diagnostic7,8 and prognostic value. Lactate is an 49 
end-product of anaerobic metabolism and its increase can indicate tissue hypoxia9,10. 50 
Therefore its role is not only relevant in assessing the degree of overt or occult 51 
hypoperfusion but also in assessing tissue oxygenation 11,12. 52 
Several studies have examined lactate in different critically ill populations and these 53 
suggest that serial lactate measurements and the change in response to therapy are a 54 
more significant prognostic indicator than the single lactate level at admission12-14. 55 
Lactate clearance, expressed as the percentage change over time of lactate level, seems to 56 
be the most sensitive prognostic indicator12,15 but interest has also been shown towards 57 
lactime, defined as time from admission taken to normalize plasma lactate 58 
concentration14. 59 
The objective of this study was to assess if elevated plasma lactate concentration at 60 
admission or lactate clearance were able to predict survival in dogs with septic 61 
peritonitis. Additional study aims were to evaluate the association between plasma 62 
lactate concentration and increased morbidity, defined as longer ICU stay, transfusion 63 
administration or pressor requirements. 64 
 65 
Materials and Methods 66 
The electronic medical records databases at a university teaching hospital were 67 
searched for cases of septic peritonitis in dogs. Inclusion criteria were a diagnosis of 68 
septic peritonitis, either on presentation or at any point during hospitalization. The 69 
criteria for diagnosis were defined as the finding of intracellular bacteria or fungal agent 70 
on cytological evaluation or on abdominal fluid culture or intra-operative evidence of 71 
macroscopic leakage of the gastro-intestinal tract or intra-abdominal rupture of an 72 
abscess or pyometra. At least one lactate measurement during the course of the 73 
hospitalization was necessary to be included in the study.  74 
Missing or incomplete records or uncertain diagnosis or euthanasia without attempted 75 
surgical treatment were exclusion criteria.  76 
Medical records for enrolled cases were reviewed by a single author. Data including 77 
signalment, relevant history, cardio-respiratory parameters, available blood work, 78 
intraoperative findings, post-operative requirements for pressors, transfusions and 79 
colloids, and outcome were recorded. Hypotension was defined as a systolic Doppler 80 
pressure less than 90 mmHg or a mean arterial pressure less than 60 mmHg when 81 
oscillometric or invasive measurement was used. Multiple organ dysfunction syndrome 82 
(MODS) was identified based on the criteria defined by Kenney et al16.  83 
APPLE scores, in full and fast form 17, were also retrospectively calculated where 84 
suitable data were available and expressed as the mortality prediction probability (score 85 
0-1).  86 
Blood lactate was measured with a bench-top blood gas analyzera using heparinized 87 
venous or arterial blood samples.  Hyperlactatemia was defined as a blood lactate 88 
concentration >2.5mmol/L18. 89 
Where available, serial blood lactate and base excess concentrations were recorded, 90 
together with their time relative to presentation and surgery. 91 
Lactate clearance, defined as the percentage change in lactate, was calculated for each 92 
case that was initially hyperlactatemic at 3, 6, 12 and 24 hours from admission as 93 
[(Lactateadm- lactatehour x)/lactatepres] x100. The plasma lactate concentration at each of 94 
these time intervals, were extracted from the medical records with a tolerance of +/- 95 
2hours, except for the 3 hour time point which was given a tolerance of ±30 minutes. 96 
Lac-time was defined as the time (hours) passed until the normalization (meant as 97 
return within the reference interval, 0-2.5 mmol/l) of lactate from admission was achieved.  98 
 99 
Statistical analysis 100 
The retrospective data were recorded in a spreadsheet using Microsoft Excelb and 101 
were analyzed with SPSSc. 102 
Each data set was analyzed for distribution using the Shapiro-Wilk test and expressed 103 
as mean (± SD) or median (range) depending on the presence or absence of a normal 104 
distribution.  105 
Continuous variables were compared with the Student’s t-test for parametric data and 106 
Mann Whitney-U test for non-parametric data. Discrete variables were analyzed for 107 
difference using ANOVA for parametric data and Kruskal-Wallis test for non-parametric 108 
data.  109 
Categorical variables were analyzed using Chi-squared or Fisher’s exact test if the 110 
contingency table contained an expected value <4.  111 
For lactate clearance and absolute plasma lactate concentration, a ROC curve was 112 
elaborated and an optimal cut-off visually defined for each time point.  113 
 114 
Results 115 
The initial medical record database search identified 363 cases. After application of 116 
the inclusion and exclusion criteria, 83 dogs with septic peritonitis were included in the 117 
study. 118 
 The median age was 60 months (range 4-142) and the median weight was 25.7 kg 119 
(range 1.7-46.1). There were a variety of breeds represented in this study with the most 120 
represented being Labradors (13), springer spaniels (8) and cross breeds (5).  Males were 121 
53/83 (64%) (36/83 (43%) neutered and 17/83 (20%) entire) and females were 30/83 122 
(36%) of the population  (spayed 20/83 (24%) and entire 10/83 (12%)).  123 
Seventy-seven (93%) were referred from another veterinary practice whereas 6/83 124 
(7%) were seen as primary emergency cases. Sixty-one (74%) of the patients received 125 
intravenous fluids at another clinic prior to presentation, while 22/83 (26%) did not 126 
receive any fluids beforehand. Forty-four (53%) had had another surgery within the 10 127 
days prior to presentation.  128 
Regarding the focus of the septic peritonitis, in 73 dogs (89%) the gastro-intestinal 129 
system was involved, in 5 dogs (6%) there was a urogenital focus, 3 dogs (4%) had 130 
hepatobiliary disease and 1 (1%) had a primary peritonitis. In terms of underlying 131 
disease, 38 dogs (46%) had a gastro-intestinal foreign body, 11 (13%) had gastro-132 
intestinal ulceration, leading to perforation, 6 (7%) were diagnosed with neoplasia, 7 133 
(8%) had intestinal biopsies, 4 (6%) had a gastric-dilation volvulus. Three (4%) had an 134 
intussusception, 2 (2.4%) each had hepatic disease, pyometra, abscessation, mesenteric 135 
volvulus, trauma and 1 (1%) each had dystocia, a mesenteric thrombus, retention of a 136 
surgical swab (gossypiboma) and a primary peritonitis.  137 
Sixty patients (72%) had a positive culture from the abdominal fluid, 3 patients had 138 
Candida Albicans isolated, 7 patients had a negative culture and 13 patients did not have 139 
a culture performed.  140 
Fifty-three (64%) of the patients survived to discharge, 18/83 (22%) were euthanized 141 
and 12/83 (14%) died during hospitalization.   142 
Median hospitalization time was 7 days (range 0-21) and the median time spent in the 143 
ICU was 3 days (range 0-17). MODS was identified in 15/83 (18%) of the patients. Median 144 
APPLE full score was 0.06 (range 0.00-0.95) and median APPLE fast score was 0.21 145 
(range 0.01-0.99). APPLE full and fast score was calculated in 46/83 patients (Table 1).  146 
On admission, the mean heart rate was 126 bpm (SD ±34), the median respiratory rate 147 
was 32 bpm (range 14-100) and the median temperature was 38.6°C (range 36-40.4). 148 
The mean systolic Doppler blood pressure recorded on admission was available for 149 
37/83 cases and was 140 mmHg (SD ± 35), with 4/83 (5%) of these dogs being 150 
hypotensive. Oscillometric blood pressure was recorded in 6/83 dogs on admission and 151 
the mean of the mean blood pressure was 85 (SD ±13). Median blood glucose was 5.8 152 
mmol/l (range 1.8-10.4).  153 
Lactate on admission was available for 81/83 cases with a median of 1.7 mmol/l 154 
(range 0.5-9.7) and median base excess for 78/83 dogs was -4.9 mmol/l (range -17.1 - 155 
+5.3) (table 2).  156 
Because of the retrospective nature of the study, plasma lactate measurements 157 
were not available for all the dogs at the different time points; complete serial 158 
lactate concentration was available for seventeen (Table 2).  159 
Synthetic colloids (hydroxyethyl starches) were used in 46/83 (55%) of the patients, 160 
human albumin in 9/83 (11%), blood products (packed red blood cells or plasma) in 161 
30/83 (36%) and vasopressors (dopamine or norepinephrine) in 16/83 (19%) of the 162 
patients.  163 
Lactate level on admission was not predictive of administration of colloids (p 0.14) or 164 
albumin (p 0.53), although it was predictive for the use of blood products (p<0.01) and 165 
vasopressors (p < 0.01). Dogs with hyperlactatemia on admission had a significantly 166 
shorter ICU stay (median 2 days, range 0-11) compared to patients presenting with 167 
normolactatemia (median 4, range 0-17) (p=0.03). When comparing only patients which 168 
survived, normolactatemic patients did not have significantly higher median total stay in 169 
the hospital (8.3 days, range 5-21) compared to the hyperlactatemic patients (8.2 days, 170 
range 4-13) (p=0.72) or have a shorter ICU stay (4 days, range 1-17) compared to the 171 
hyperlactatemic patients (4.5 days, range 1-11) (p=0.73). These numbers need to be 172 
interpreted in light of the retrospective nature of the study with the length in the ICU and 173 
the discharge time being clinician and finance-based.   174 
Twenty-four (29%) patients had hyperlactatemia on admission and 14 of these dogs 175 
did not survive. Hyperlactatemia on admission was associated with mortality (p=0.01) 176 
(Figure 1).  177 
Lactate on admission higher than 4 mmol/l was significantly associated with mortality 178 
(odds ratio 7.1, 95% C.I 2-25, p=0.002). 15/81 patients had lactate on admission higher 179 
than 4 mmol/l. Of these (11/15) 73% of the patients died, versus (19/68) 28% of the 180 
patients with a lactate < 4 mmol/l.  A lactate higher than 4 mmol/l on admission yielded 181 
a sensitivity of 36% and a specificity of 92% for non-survival.  182 
Lactime could be calculated for 24 dogs of which 13 patients died and 11 survived. Of 183 
the 24 dogs, 10 failed to resolve hyperlactatemia (ranging from 1 hour to 24 hours) over 184 
the documented measurements and all of these patients did not survive. Of the remaining 185 
14 patients that did have resolution of hyperlactatemia, 11 survived and 3 did not survive.  186 
An ROC curve of the lactime yielded poor sensitivity and specificity for survival with 187 
an area under the curve of 0.66.  188 
Data regarding resolution of hyperlactatemia within 6 hours were available for 24 189 
dogs. All the patients that did not clear lactate within 6 hours died (10/10). Of the dogs 190 
which cleared their hyperlactatemia within 6 hours (14/24), 11 (79%) survived and 3 191 
(21%) died. The inability to clear lactate within 6 hours yielded a sensitivity of 76% and 192 
specificity of 100% for non-survival. 193 
Lactate post-surgery was recorded in 76 dogs. Post-operative hyperlactatemia was 194 
present in 18 dogs, 12 of which died (p=0.02). Of the 58 dogs which were not 195 
hyperlactatemic post-operatively, 14 died (24%) and 44 survived (76%). Post-operative 196 
hyperlactatemia had a sensitivity of 46% and specificity of 88% for non-survival.  197 
Persistent post-operative hyperlactatemia was significantly associated with mortality 198 
(p < 0.001). Of 18 dogs which were hyperlactatemic postoperatively, 11 failed to clear 199 
lactate. Off these eleven dogs, 4 had normal lactate concentration on admission but 200 
all of them (11/11, 100%) did not survive to discharge. Of the remaining 7 dogs with 201 
post-operative hyperlactatemia that resolved, 6 survived and 1 did not survive despite 202 
clearing lactate. Persistent hyperlactatemia post-operatively yielded a sensitivity of 92% 203 
and a specificity of 100% for non-survival.  204 
An ROC curve was generated for lactate concentration at 6 hours (55/83) following 205 
admission which had an AUC of 0.87 with a cut-off 2.3 mmol/l yielding a sensitivity of 206 
68% and specificity of 92% for non-survival. Lactate clearance at 6 hours could be 207 
calculated for 20 patients and ROC curve analysis produced an AUC of 0.81 with a 208 
sensitivity 54% and specificity 91% for non-survival at 21% clearance. 209 
Absolute lactate concentration at 12 hours post admission produced an ROC curve 210 
with an AUC of 0.86 (n=54) with a cut-off of 2.4 mmol/l resulting in a sensitivity of 54% 211 
and a specificity of 100% for non-survival. Lactate clearance at 12 hours post-admission 212 
could be calculated for 18 patients and ROC curve analysis produced a curve with an AUC 213 
of 0.90 and an optimal cut-off of 42% resulted in a sensitivity of 82% and specificity of 214 
100% for non-survival (Figure 2). 215 
Lactate clearance was not significantly different between survivors and non-survivors 216 
at 3 hours post admission (n=9, p=0.25). 217 
218 
Discussion 219 
Septic peritonitis is a complex and severe process with fluid loss and systemic 220 
inflammation caused by infectious agents in the peritoneal cavity and the causative 221 
underlying disease. Interactions between the inflammatory response, the coagulation 222 
and endothelial systems may lead to abnormalities in the macro- and micro-circulation, 223 
multi-organ failure and ultimately death. Hypoperfusion may occur through various 224 
pathophysiologic pathways, including hypovolemia, cardiogenic shock, vasoplegia, and 225 
splanchnic microthrombi 19 226 
Hyperlactatemia either represents an imbalance between tissue oxygen supply and 227 
demand (type A) or altered cellular metabolism (type B). In septic patients 228 
hyperlactatemia may occur due to hypoperfusion, mitochondrial dysfunction, increased 229 
leukocyte activity, organ dysfunction, decreased lactate clearance, Na+-K+ ATPase 230 
activation, hypoglycemia or dysregulation of pyruvate dehydrogenase 9,20,21,22. Recent 231 
veterinary studies have found neoplasia to be a cause of increased lactate but typically 232 
this is not clinically significant and was unlikely to be a significant confounder in our 233 
study as a neoplastic process was only identified in 7% of the enrolled patients23,24. 234 
Similarly, the presence of a primary liver disease (2 patients), steroid administration 235 
(documented in 4 patients) or the use of cathecolamines could have increased the lactate 236 
serum levels and should be considered possible confounders of our study10,24.  237 
In our study lactate at admission was significantly different between survivors and 238 
non-survivors, although median lactate for non-survivors (2.5 mmol/L) was only the 239 
upper reference limit of 2.5mmol/l outlined by a previous study18. This suggests that 240 
even moderate increase in lactate should be concerning, warranting immediate attention 241 
to the patient. Alternatively, a median lactate concentration within normal limits on 242 
admission in non survivors may be suggesting that at this time point lactate is not 243 
predictive of death.  In previous veterinary studies lactate on admission has achieved 244 
different significance. In a study on a heterogenous population of systemically ill dogs it 245 
was not found to be significantly associated with mortality12; in patients with IMHA 246 
survivors had a lower lactate on admission (median 2.9 mmol/l) in comparison to non-247 
survivors (4.8 mmol/l)14. In dogs with Babesiosis the difference between survivors and 248 
non-survivors was more marked (2.6 mmol/l in survivors vs 8.5 mmol/l in non-249 
survivors) and significant 15.  These findings suggest that perhaps lactate values should 250 
be interpreted differently according to the underlying pathophysiologic process involved 251 
and therefore should always be considered within a disease-related context. 252 
 Severe hyperlactatemia on admission was defined as lactate higher than 4 mmol/l and 253 
was associated with a higher mortality. These results are in accordance with studies in 254 
human patients in which hyperlactatemia was associated with a higher mortality, 255 
independent of organ failure or shock25 and that a lactate higher than 4 mmol/l at 256 
admission was associated with a six-fold higher probability for death within 3 days26. A 257 
retrospective study on dogs with IMHA showed that a cut-off of 4.4 mmol/l on admission 258 
was a good predictor of survival14. In dogs with gastric dilation-volvolus an admission 259 
lactate of < 4.1 mmol/l was the best cut-off based on a ROC curve analysis for predicting 260 
survival27.  261 
Interestingly, and in contrast to another veterinary study in trauma patients6 base 262 
excess on admission was not significantly associated with survival in this study (p=0.17), 263 
highlighting that base excess can vary for reasons unrelated to lactate accumulation in 264 
septic patients. A reduction in standard base excess and consequent metabolic acidosis is 265 
likely multifactorial in sepsis, and the contribution of lactate can be less than 10%28 . 266 
Other contributing factors to acidosis could be represented by hyperchloremia, 267 
accumulation of inorganic unmeasured ions (e.g keto acids or sulfate) or by a metabolic 268 
alkalosis by hypoalbuminemia29. 269 
Lactate on admission was associated with patient morbidity in this study, with a higher 270 
median lactate reported for dogs that required transfusions or vasopressors. Anemia 271 
and hypotension induce tissue hypoxia, due to reduced oxygen delivery and tissue 272 
perfusion respectively. It is assumed that patients that received transfusions or 273 
vasopressors had higher plasma lactate concentration ascribable to their anemia or 274 
hypotension but due the retrospective nature of the study we cannot exclude that high 275 
lactate was an actual indication for blood transfusion administration or vasopressor 276 
therapy. Somewhat surprisingly, hyperlactatemia was associated with a shorter ICU stay 277 
in this patient population. This finding is likely explained by the early euthanasia or death 278 
of this population. 279 
Lactate was recorded at 3 hours and at 6, 12 and 24 +/- 2 hours after admission when 280 
available. The best area under ROC curves for absolute plasma concentration were 281 
obtained at 6 and 12 hours post admission; lactate level higher than 2.3 mmol/l at 6 hours 282 
or higher than 2.4 mmol/l at 12 hours were good predictors of mortality (specificity 92% 283 
and 100% respectively). These levels are only mildly elevated or within the reference 284 
range suggesting that the single value should be critically interpreted in consideration of 285 
the disease affecting the patient or that higher levels of lactate, but still within the normal 286 
limits established in healthy dogs, could indicate inadequate tissue oxygenation and the 287 
need for more medical attention. In addition, the low sensitivity for mortality of the 288 
cut-offs at 6 and 12 hours suggest that lactate concentration below these 289 
concentration should not decrease the clinicians’ concern for these patients which 290 
are still at risk or mortality.  291 
The percentage clearance of lactate at 6 and 12 hours after admission was also found 292 
to be a good predictor of mortality in this study. This is in accordance with the findings of 293 
Stevenson et al.12 who examined systemically ill dogs with a variety of diseases and found 294 
that lactate clearance <50% at 6 hours after admission was associated with mortality. 295 
Similarly, Nel et al.15  found that a lactate clearance <50% at 8 and 16 hours after 296 
admission was a poor prognostic indicator in canine babesiosis. Additionally, failure to 297 
normalise lactate within 6 hours of admission has been found to be associated with 298 
mortality in dogs with immune mediated hemolytic anemia14. Similar results have been 299 
found in septic people; lactate clearance at 6 hours was shown to be prognostically 300 
superior to central venous saturation of oxygen (ScvO2)30 and a 24 hours window for 301 
lactate clearance was also a good predictor of survival31.  302 
There are several limitations to this study, most of which are intrinsic to its 303 
retrospective design. The majority of the patients (93%) included in the study was 304 
referred from another veterinarian and may have received treatment and in some cases 305 
even had surgery prior referral. As a result lactate measurements taken at the same time 306 
from admission may not represent the same stage of the disease in different patients. The 307 
lactate values were extracted from records rather than being prospectively timed and 308 
this likely led to more data points being available in the sickest patients. It is assumed 309 
that stable patients with normal lactate recorded continued to have normal lactate but in 310 
patients with hyperlactatemia on admission samples were serially measured to look for 311 
normalization.  312 
The number of patients for which lactate was available at our predetermined time-313 
points was low and therefore the power of the study when looking at lactate at time 314 
points other than admission is reduced. Also the +/- 2 hours tolerance for the time points 315 
might actually have influenced the results; a further prospective study with sampling 316 
performed at the time set could overcome the limitation of this retrospective study. The 317 
ability to euthanize patients is another limitation inherent to many veterinary studies. 318 
Given that the majority of patients were referred from another centre it is likely that 319 
financial constraints and owner motivation were less of a confounding factor in this 320 
population. The difference in APPLE scoring between the survivors and non-survivors 321 
supports the notion that mortality in this population was associated with disease severity 322 
rather than socioeconomic factors.  In addition, the results regarding the 323 
hospitalization and ICU time or discharge time need to be interpreted with caution 324 
in this retrospective study, as these times can often be clinician and finance-based.   325 
In conclusion, this study showed that in dogs with septic peritonitis lactate was 326 
associated with mortality and morbidity. In particular the results suggest that lactate 327 
clearance within a 6 to 12 hour window is associated with mortality and that post-328 
operative hyperlactatemia should raise particular concerns. Further prospective studies 329 
are needed in order to assess the potential role of lactate-guided therapy in sepsis.  330 
331 
Footnotes:  332 
a. Critical Care Xpress and Phox Ultra, Nova Biomedical 333 
b. Microsoft Excell, version 2008, Microsoft Inc.  334 
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  444 
Table 1: Various parameters in dogs with septic peritonitis compared between 445 
survivors and non-survivors. Data presented as mean (+/- SD) or median (range). A p 446 
value of <0.05 was considered statistically significant. 447 
 SURVIVORS  NON-SURVIVORS P value 
Heart rate (bpm) 117 (±32) 141 (±30) 0.001 
Respiratory rate (brpm) 32 (14-100) 32 (20-100) 0.6 
Temperature (C°) 38.6 (36.3-
40.3) 
38.4 (36-40.1) 0.52 
Doppler systolic pressure 
(mmHg) 
145 (±26) 121 (±42) 0.04 
Blood glucose (mmol/l) 5.7 (2.9-
10.9) 
6.3 (1.8-9.6) 0.16 




1.1 (0.87-1.34) 0.013 
Lactate adm. (mmol/l) 1.4 (0.5-9.7) 2.5 (0.5-8.4) 0.007 
Base excess adm. (mmol/l) -4.8 (-15- -
0.2) 
- 6.2 (-17.1-5.3) 0.17 
ICU stay (days) 4 (1-17) 3 (0-11) 0.039 
Hospital  stay (days) 7 (4-21) 3 (0-12) 0.001 
Time of administration of 
antibiosis from admission 
(hours) 
3 (0-48) 3 (1-56) 0.72 
Time from admission to 
surgery (hours) 
3 (1-48) 3 (1-56) 0.83 
APPLE full  0.03 (0-
0.38) 
0.2 (0.01-0.95) 0.001 
APPLE fast 0.13(0.01-
0.77) 




Table 2: Median plasma lactate concentration (range) in  survivors and non survivors. 451 
P value is expressed on the right side of the table.  452 
 Survivors  Non survivors P value 








Lactate 3 hours 1 (0.5-7.2)  
(n=15) 
 






























  454 
Figure 1: Box and whiskers plot representing median lactate and interquartile range 455 
(box) at different time points from admission in survivors and non-survivors.  The black 456 
dots represent outliers. Significance was determined with a p value < 0.05. A significant 457 
difference between the two groups was detected at admission, 6hours, 12 hours and 24 458 
hours post-admission.  459 
 460 
  461 
Figure 2: ROC analysis of lactate clearance at 12 hours following admission for prediction 462 
of non-survival in hyperlactatemic dogs with septic peritonitis (AUC 0.90).  463 
 464 
